Report of the Independent Allocation of Vaccines Group on the allocation of COVAX Facility secured vaccines: 15 March 2021

Overview

The purpose of this document is to provide transparency on the deliberations of the IAVG in their analysis and validation of the JAT’s revised Vaccine Allocation Decision (VAD) proposal for the allocation of BNT162b2/COMIRNATY Tozinameran (INN) “Pfizer” vaccine, which is among the COVAX Facility secured vaccines.